Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proactive Delgocitinib Ointment for Maintenance of Remission in Atopic Dermatitis
jRCTs031230314Active, not recruiting
- Sponsor
- Torii Pharmaceutical
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of delgocitinib in atopic dermatitis (AD) (2 arms), sponsored by Torii Pharmaceutical. Primary endpoint: Cumulative number of days with vIGA scores of 0 and 1. Started Nov 2023; status: active, not recruiting.
02
Drugs
delgocitinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCTs031230314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230314.